News Headlines Article

Researchers find reason pancreatic cancer resists chemotherapy drug
Washington Post

Researchers have identified one reason pancreatic cancer is so resistant to chemotherapy treatment: vitamin D.

Only about 5 percent of pancreatic-cancer patients survive beyond five years even with the most aggressive treatment, according to the National Cancer Institute. One big reason is that chemotherapy — including the standard drug, gemcitabine — isn’t very effective at preventing pancreatic cancer cells from replicating.